0
Upcoming Allied Market Research
2023
Bionic Devices Market

Bionic Devices Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A10887
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Bionic Devices Market

Request Now !

Bionic devices are implants that replace biological functions lost due to nerve damage. They use electrical signals to stimulate the remaining nerve cells following disease or injury. Currently, the bionic eye is under development with several groups across the globe seeking to provide a viable device for enabling sight impaired patients to perceive light. Pacemakers were the first bionic device types but have been expanded to include not only cardiac pacemakers, but also urinary and diaphragm pacing devices. Similarly implantable electrodes have been used for functional electrical stimulation, encompassing a range of devices which enable movement of muscles in patients with nerve damage, such as paraplegics. These devices perform functions which can include limb movement, sphincter and erectile control. The more widely recognized bionic devices are the cochlear implant and the bionic eye. Actively stimulated nerve guides for repairing nerve injury and stimulated wound healing electrodes may also be considered bionic devices.

Covid-19 Scenario analysis:

The COVID-19 pandemic poses special challenges to patients who require Bionic transplants. Those waiting for transplant or who had received a transplant tend to have more severe disease due to weak immunity. Patients with severe heart, lung, or liver failure and waiting for transplant are at a high risk for dying if a transplant does not happen within a short period of time. But if there are clusters of COVID-19 disease in the region around the hospital or if there are COVID-19 patients already admitted in the hospital then, the course ahead becomes a quandary. Performing a transplant surgery in such situation will increase the risk of exposure to the recipient during the surgery and in the recovery period. This exposure could happen from the donor or healthcare providers or other patients in the hospital. It is possible that the hospital resources could become limited due to COVID-19 cases and the care of the transplant recipients may get compromised. Non-urgent transplant surgeries such as kidney transplants in relatively stable patients on dialysis may be avoided in areas of high prevalence of COVID-19. If the recipient is critically ill and the surgery is unavoidable then care has to be taken to check both the donor and the recipient for COVID-19 prior to transplant. All these health hazard have resulted in a slowdown in the bionic transplant market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:

Drivers:

Technological developments:

Bionic technology can be defined as the flow of concepts from engineering to biology and vice versa. The advancement in bionic technology over the years has helped scientists to create various innovative materials that enhance human ability. Bionic devices such as prosthetic arms and prosthetic legs have even helped people with disabilities lead a normal life. But science fiction has literally raised expectation, and researchers and innovators all over the globe are putting best of their efforts to build bionic tech that could someday actually make superhuman. Some examples are:

The H.U.L.C exoskeleton with a titanium body was developed by Berkley Bionics and Lockheed Martin mainly keeping soldiers in mind. It is a 3rd gen exoskeleton, which allows the wearer to easily lift up to 200 pounds of weight and also decreases the amount of metabolic energy required by the wearer. The exoskeleton essentially provides a person with superhuman capabilities by increasing the strength as well as endurance.

The bionic lens is a proposition by many developers and manufacturers that will have a virtual display and could have multiple uses from improving eyesight to video gaming. A company called Ocumetics Technology Corporation is at the forefront of this technology.

A large portion of people in the world is insulin dependent due to diabetic problems. These people not only have to keep a control on the food items they eat but also have to go through the trouble of taking insulin regularly. However, the Juvenile Diabetes Research Foundation is in the process of creating an artificial pancreas, which will be able to monitor the sugar levels in the blood and adjust the insulin levels of the body accordingly.

Increased number of road accidents causing a need of Bionic body parts:

Road traffic accidents is the leading cause of death by injury and the tenth-leading cause of all deaths globally, which now make up a surprisingly significant portion of the worldwide burden of ill-health. An estimated 1.2 million people are killed in road crashes each year, and as many as 50 million are injured, occupying 30% to 70% orthopedic beds in hospitals in developing countries and if present trends continue, road traffic injuries are predicted to be the third-leading contributor to the global burden of disease and injury by 2020. This drastic increase in road accidents has resulted in broken and lost limbs. The bionic devices provide these people with a second chance at life and thus, the market is at steady growth.

Restrains:

Current bionic devices typically use metal electrodes to stimulate the nerve cells. While these electrodes have been sufficient for the past few decades and in devices which are implanted for only a few years, these metal electrodes are now becoming a limitation. As the miniaturization of electronics continues to allow us to reduce the size of implants and offer patients devices with more functionality, there is a need to create smaller, more densely packed electrodes. At these sub-micron sizes, metal electrodes cannot be safely used for multiple decades, as is now required by cochlear implant patients who receive devices as children. As a result there is significant interest in new electrode materials.

Over this time there have been developed a number of electrically conductive materials which can improve on the performance of conventional metallic electrodes. However, since these materials are still recognized by the human body as foreign, they still suffer from a process known as fibrous encapsulation, where the body produces scar-like cells which surround and wall off the implant. An optimal implant will form an intimate connection with the surrounding cells, without inciting growth of scar tissue.

Key benefits of the report:

  • This study presents the analytical depiction of the global Bionic devices industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Bionic devices market share.
  • The current market is quantitatively analyzed to highlight the global Bionic devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Bionic devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Bionic devices Market research report:

  • What are the leading market players active in the Bionic devices market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Bionic Devices Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Type
  • Vision Bionics
  • Ear Bionics
  • Orthopedic Bionic
  • Cardiac Bionics
By Material
  • Tungsten
  • Silicon
  • Platinum-iridium
  • Stainless steel
  • Biologics
By End User
  • Hospitals & clinics
  • Research & academic institutes
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Varjo Technologies,, AlterG,, Mobius Bionics,, Össur., Festo,, Nano Retina,, Pixium Vision. ,, Ekso Bionics,, Open Bionics,, AGTC,, ReWalk Robotics.,
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: BIONIC DEVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Vision Bionics

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Ear Bionics

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Orthopedic Bionic

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Cardiac Bionics

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: BIONIC DEVICES MARKET, BY MATERIAL

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Material

    • 5.2. Tungsten

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Silicon

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Platinum-iridium

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Stainless Steel

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Biologics

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

  • CHAPTER 6: BIONIC DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals Clinics

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Research Academic Institutes

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: BIONIC DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Material

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Bionic Devices Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Material
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Bionic Devices Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Material
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Bionic Devices Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Material
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Material

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Bionic Devices Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Material
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Bionic Devices Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Material
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Bionic Devices Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Material
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Bionic Devices Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Material
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Bionic Devices Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Material
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Bionic Devices Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Material
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Bionic Devices Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Material
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Material

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Bionic Devices Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Material
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Bionic Devices Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Material
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Bionic Devices Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Material
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Bionic Devices Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Material
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Bionic Devices Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Material
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Bionic Devices Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Material
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Bionic Devices Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Material
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Bionic Devices Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Material
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Bionic Devices Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Material
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Material

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Bionic Devices Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Material
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Bionic Devices Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Material
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Bionic Devices Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Material
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Bionic Devices Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Material
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Bionic Devices Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Material
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Bionic Devices Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Material
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Varjo Technologies,

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Open Bionics,

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. AlterG,

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. AGTC,

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Pixium Vision. ,

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. ReWalk Robotics.,

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Festo,

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Ekso Bionics,

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Mobius Bionics,

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Nano Retina,

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Össur.

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL BIONIC DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL BIONIC DEVICES MARKET FOR VISION BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL BIONIC DEVICES MARKET FOR EAR BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL BIONIC DEVICES MARKET FOR ORTHOPEDIC BIONIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL BIONIC DEVICES MARKET FOR CARDIAC BIONICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL BIONIC DEVICES MARKET, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL BIONIC DEVICES MARKET FOR TUNGSTEN, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL BIONIC DEVICES MARKET FOR SILICON, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL BIONIC DEVICES MARKET FOR PLATINUM-IRIDIUM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL BIONIC DEVICES MARKET FOR STAINLESS STEEL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL BIONIC DEVICES MARKET FOR BIOLOGICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL BIONIC DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL BIONIC DEVICES MARKET FOR HOSPITALS CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL BIONIC DEVICES MARKET FOR RESEARCH ACADEMIC INSTITUTES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL BIONIC DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL BIONIC DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA BIONIC DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 20. NORTH AMERICA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. U.S. BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 22. U.S. BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 23. U.S. BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. CANADA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 25. CANADA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 26. CANADA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 29. MEXICO BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE BIONIC DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 33. EUROPE BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 39. GERMANY BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 42. ITALY BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. UK BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 47. UK BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 48. UK BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 51. RUSSIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 54. REST OF EUROPE BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC BIONIC DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 58. ASIA-PACIFIC BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. CHINA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. CHINA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 61. CHINA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 64. JAPAN BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. INDIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 66. INDIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 67. INDIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 70. SOUTH KOREA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 73. AUSTRALIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 76. THAILAND BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 79. MALAYSIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 82. INDONESIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA BIONIC DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 89. LAMEA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 92. BRAZIL BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 98. SAUDI ARABIA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. UAE BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 100. UAE BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 101. UAE BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 104. ARGENTINA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA BIONIC DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA BIONIC DEVICES, BY MATERIAL, 2022-2032 ($MILLION)
  • TABLE 107. REST OF LAMEA BIONIC DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. VARJO TECHNOLOGIES,: KEY EXECUTIVES
  • TABLE 109. VARJO TECHNOLOGIES,: COMPANY SNAPSHOT
  • TABLE 110. VARJO TECHNOLOGIES,: OPERATING SEGMENTS
  • TABLE 111. VARJO TECHNOLOGIES,: PRODUCT PORTFOLIO
  • TABLE 112. VARJO TECHNOLOGIES,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 113. OPEN BIONICS,: KEY EXECUTIVES
  • TABLE 114. OPEN BIONICS,: COMPANY SNAPSHOT
  • TABLE 115. OPEN BIONICS,: OPERATING SEGMENTS
  • TABLE 116. OPEN BIONICS,: PRODUCT PORTFOLIO
  • TABLE 117. OPEN BIONICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 118. ALTERG,: KEY EXECUTIVES
  • TABLE 119. ALTERG,: COMPANY SNAPSHOT
  • TABLE 120. ALTERG,: OPERATING SEGMENTS
  • TABLE 121. ALTERG,: PRODUCT PORTFOLIO
  • TABLE 122. ALTERG,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 123. AGTC,: KEY EXECUTIVES
  • TABLE 124. AGTC,: COMPANY SNAPSHOT
  • TABLE 125. AGTC,: OPERATING SEGMENTS
  • TABLE 126. AGTC,: PRODUCT PORTFOLIO
  • TABLE 127. AGTC,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 128. PIXIUM VISION. ,: KEY EXECUTIVES
  • TABLE 129. PIXIUM VISION. ,: COMPANY SNAPSHOT
  • TABLE 130. PIXIUM VISION. ,: OPERATING SEGMENTS
  • TABLE 131. PIXIUM VISION. ,: PRODUCT PORTFOLIO
  • TABLE 132. PIXIUM VISION. ,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 133. REWALK ROBOTICS.,: KEY EXECUTIVES
  • TABLE 134. REWALK ROBOTICS.,: COMPANY SNAPSHOT
  • TABLE 135. REWALK ROBOTICS.,: OPERATING SEGMENTS
  • TABLE 136. REWALK ROBOTICS.,: PRODUCT PORTFOLIO
  • TABLE 137. REWALK ROBOTICS.,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 138. FESTO,: KEY EXECUTIVES
  • TABLE 139. FESTO,: COMPANY SNAPSHOT
  • TABLE 140. FESTO,: OPERATING SEGMENTS
  • TABLE 141. FESTO,: PRODUCT PORTFOLIO
  • TABLE 142. FESTO,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 143. EKSO BIONICS,: KEY EXECUTIVES
  • TABLE 144. EKSO BIONICS,: COMPANY SNAPSHOT
  • TABLE 145. EKSO BIONICS,: OPERATING SEGMENTS
  • TABLE 146. EKSO BIONICS,: PRODUCT PORTFOLIO
  • TABLE 147. EKSO BIONICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 148. MOBIUS BIONICS,: KEY EXECUTIVES
  • TABLE 149. MOBIUS BIONICS,: COMPANY SNAPSHOT
  • TABLE 150. MOBIUS BIONICS,: OPERATING SEGMENTS
  • TABLE 151. MOBIUS BIONICS,: PRODUCT PORTFOLIO
  • TABLE 152. MOBIUS BIONICS,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 153. NANO RETINA,: KEY EXECUTIVES
  • TABLE 154. NANO RETINA,: COMPANY SNAPSHOT
  • TABLE 155. NANO RETINA,: OPERATING SEGMENTS
  • TABLE 156. NANO RETINA,: PRODUCT PORTFOLIO
  • TABLE 157. NANO RETINA,: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 158. ÖSSUR.: KEY EXECUTIVES
  • TABLE 159. ÖSSUR.: COMPANY SNAPSHOT
  • TABLE 160. ÖSSUR.: OPERATING SEGMENTS
  • TABLE 161. ÖSSUR.: PRODUCT PORTFOLIO
  • TABLE 162. ÖSSUR.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL BIONIC DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL BIONIC DEVICES MARKET
  • FIGURE 3. SEGMENTATION BIONIC DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN BIONIC DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALBIONIC DEVICES MARKET
  • FIGURE 11. BIONIC DEVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. BIONIC DEVICES MARKET FOR VISION BIONICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. BIONIC DEVICES MARKET FOR EAR BIONICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. BIONIC DEVICES MARKET FOR ORTHOPEDIC BIONIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. BIONIC DEVICES MARKET FOR CARDIAC BIONICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. BIONIC DEVICES MARKET SEGMENTATION, BY BY MATERIAL
  • FIGURE 17. BIONIC DEVICES MARKET FOR TUNGSTEN, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. BIONIC DEVICES MARKET FOR SILICON, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. BIONIC DEVICES MARKET FOR PLATINUM-IRIDIUM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. BIONIC DEVICES MARKET FOR STAINLESS STEEL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. BIONIC DEVICES MARKET FOR BIOLOGICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. BIONIC DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 23. BIONIC DEVICES MARKET FOR HOSPITALS CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. BIONIC DEVICES MARKET FOR RESEARCH ACADEMIC INSTITUTES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. BIONIC DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 28. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 29. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 30. COMPETITIVE DASHBOARD
  • FIGURE 31. COMPETITIVE HEATMAP: BIONIC DEVICES MARKET
  • FIGURE 32. Top player positioning, 2022
  • FIGURE 33. VARJO TECHNOLOGIES,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. VARJO TECHNOLOGIES,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. VARJO TECHNOLOGIES,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. OPEN BIONICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. OPEN BIONICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. OPEN BIONICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. ALTERG,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. ALTERG,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. ALTERG,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. AGTC,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. AGTC,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. AGTC,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. PIXIUM VISION. ,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. PIXIUM VISION. ,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. PIXIUM VISION. ,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. REWALK ROBOTICS.,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. REWALK ROBOTICS.,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. REWALK ROBOTICS.,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. FESTO,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. FESTO,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. FESTO,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. EKSO BIONICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. EKSO BIONICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. EKSO BIONICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. MOBIUS BIONICS,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MOBIUS BIONICS,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. MOBIUS BIONICS,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 60. NANO RETINA,: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 61. NANO RETINA,: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 62. NANO RETINA,: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 63. ÖSSUR.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 64. ÖSSUR.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 65. ÖSSUR.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Bionic Devices Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers